In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion

In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion

Abstract Despite the poor prognosis associated with myelomeningocele (MMC), the options for prenatal treatments are still limited. Recently, fetal cellular therapy has become a new option for treating birth defects, although the therapeutic effects and mechanisms associated with such treatments rema...

Full description

Bibliographic Details
Main Authors: Yushi Abe, Daigo Ochiai, Hirotaka Masuda, Yu Sato, Toshimitsu Otani, Marie Fukutake, Satoru Ikenoue, Kei Miyakoshi, Hideyuki Okano, Mamoru Tanaka
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Stem Cells Translational Medicine
Subjects:
Amniotic fluid stem cells
Fetal cellular therapy
Hepatocyte growth factor
Myelomeningocele
Spinal cord
Online Access:https://doi.org/10.1002/sctm.19-0002

Internet

https://doi.org/10.1002/sctm.19-0002

Similar Items